RAPTOR PHARMACEUTICAL CORP - COM (RPTP)

CUSIP: 75382F106

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
28,673,670
Share change
+130
Total reported value
$373,487,553
Put/Call ratio
42%
Price per share
$13.02
Number of holders
67
Value change
-$29,000
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 75382F106?
CUSIP 75382F106 identifies RPTP - RAPTOR PHARMACEUTICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RAPTOR PHARMACEUTICAL CORP - COM (RPTP) as of Q4 2013

As of 31 Dec 2013, RAPTOR PHARMACEUTICAL CORP - COM (RPTP) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,673,670 shares. The largest 10 holders included CREDIT SUISSE AG/, FMR LLC, ROYAL BANK OF CANADA, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, NORTHERN TRUST CORP, and NOMURA HOLDINGS INC. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.